ca (Worthington Biochemical)
Structured Review
Ca, supplied by Worthington Biochemical, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cas/ca/custom%40ca%4042547993
Average 99 stars, based on 1 article reviews
Images
Related Articles
Flow Cytometry:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Analysis:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Glass:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Imaging:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with FISH:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Isolation:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Oligomer Restriction:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Cytometry:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Suspension:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Expressing:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Saline:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Plasmid Preparation:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with Mouse Assay:Article Title: Chamber-specific regulation of myofilament Ca 2+ sensitivity by nNOSβ via troponin I phosphorylation: Predominance in the right ventricle Article Snippet: a constant flow rate (8–10 ml·min −1 ) according to the following sequence: (1) 8 min with |
![( A ) Schematics of the four possible degradation pathways that CaMKIV-phosphorylated REST can undertake and the three inhibitors that were used to dissect the fate of REST. Cat, cathepsin. ( B ) HEK293T cells were transfected with WT, CA, or KD CaMKIV and treated with cycloheximide (CHX) to in4hibit further translation. Then, cells were treated for 16 hours with either vehicle [dimethyl sulfoxide (DMSO)] or MG-132 (5 μM), an inhibitor of the ubiquitin-proteasome system (UPS). Left: Representative immunoblots monitoring the expression of WT, CA, and KD CaMKs, REST, and calnexin, respectively, in HEK293T cells, 48 hours after transfection with the kinase constructs. Right: Mean (±SEM) REST protein levels, shown as ratios with calnexin immunoreactivity under the various experimental conditions. No effects of inhibition of the UPS were observed. * P = 0.017, CA versus WT in DMSO; ** P = 0.0048, CA versus WT in MG-132. Two-way ANOVA/Tukey’s tests ( n = 4 independent preparations). ( C ) HEK293T cells were transfected with either WT or CA CaMKIV and treated with CHX to inhibit further translation. Successively, cells were treated for 16 hours with DMSO (Veh), bafilomycin A1 (Baf; 100 nM; an inhibitor of lysosomal acidification and autophagy), leupeptin (Leu; 40 μM; an inhibitor of the lysosomal and cytosolic proteases), <t>CA074</t> (a specific inhibitor of Cathepsin B), or E64 (an inhibitor of cathepsins). Left: Representative immunoblots monitoring the expression of REST, calnexin, and the autophagy markers p62 and LC3B-I and -II. Right: Mean (±SEM) REST/calnexin ratios normalized with respect to the control REST/calnexin ratio in WT CaMKIV–expressing cells. Leu, * P = 0.0351; CA074, * P = 0.0361; E64, * P = 0.0481. Mixed-effects ANOVA/Dunnett’s tests ( n = 4 independent preparations).](https://pub-med-central-images-cdn.bioz.com/pub_med_central_ids_ending_with_4487/pmc13674487/pmc13674487__sciadv.aec0781-f3.jpg)
